Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 73-79 , September 2007

Age-related factors in child heart transplants

  • Daphne T. Hsu

      Affiliations

    • Corresponding Author InformationMorgan Stanley Children's Hospital of New York, Room 221N, 3959 Broadway, New York, New York 10032, United States.Tel.: +1 212 342 1560; fax: +1 212 342 1563.

References 

  1. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348(17):1647–1655
  2. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348(17):1639–1646
  3. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the International Society for Heart and Lung Transplantation: ninth official pediatric heart transplantation report-2006. J Heart Lung Transplant. 2006;25(8):893–903
  4. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296(15):1867–1876
  5. Morrow WR, Naftel D, Chinnock R, et al. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant. 1997;16(12):1255–1266
  6. Bae JO, Frischer JS, Waich M, Addonizio LJ, Lazar EL, Stolar CJ. Extracorporeal membrane oxygenation in pediatric cardiac transplantation. J Pediatr Surg. 2005;40(6):1051–1056[discussion 1056–7]
  7. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113(19):2313–2319
  8. Levi D, Marelli D, Plunkett M, et al. Use of assist devices and ECMO to bridge pediatric patients with cardiomyopathy to transplantation. J Heart Lung Transplant. 2002;21(7):760–770
  9. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345(20):1435–1443
  10. BarZiv SM, McCrindle BW, West LJ, et al. Outcomes of pediatric patients bridged to heart transplantation from extracorporeal membrane oxygenation support. ASAIO J. 2007;53(1):97–102
  11. Duncan BW, Hraska V, Jonas RA, et al. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg. 1999;117(3):529–542
  12. Fiser WP, Yetman AT, Gunselman RJ, et al. Pediatric arteriovenous extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation. J Heart Lung Transplant. 2003;22(7):770–777
  13. Hetzer R, Potapov EV, Stiller B, et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg. 2006;82(3):917–924[discussion 924–5]
  14. Baldwin JT, Borovetz HS, Duncan BW, et al. The National Heart, Lung, and Blood Institute Pediatric Circulatory Support Program. Circulation. 2006;113(1):147–155
  15. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology–drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349(12):1157–1167
  16. del Mar Fernandez De Gatta M, Santos-Buelga D, Dominguez-Gil A, Garcia MJ. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. Clin Pharmacokinet. 2002;41(2):115–135
  17. Kavukcu S, Soylu A, Turkmen M, Kasap B, Gumustekin M, Gulay H. Two-hour post-dose cyclosporin A levels in adolescent renal transplant recipients in the late post-transplant period. Pediatr Nephrol. 2004;19(6):667–671
  18. Dipchand AI, Pietra B, McCrindle BW, Rosebrook-Bicknell HL, Boucek MM. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. J Heart Lung Transplant. 2001;20(10):1035–1043
  19. Schachter AD, Benfield MR, Wyatt RJ, et al. Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. Pediatr Transplant. 2006;10(8):914–919
  20. Sindhi R. Sirolimus in pediatric transplant recipients. Transplant Proc. 2003;35(3 Suppl):113S–114S
  21. Hedman M, Neuvonen PJ, Neuvonen M, Holmberg C, Antikainen M. Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression. Clin Pharmacol Ther. 2004;75(1):101–109
  22. Wray J, Pot-Mees C, Zeitlin H, Radley-Smith R, Yacoub M. Cognitive function and behavioural status in paediatric heart and heart–lung transplant recipients: the Harefield experience. BMJ. 1994;309(6958):837–841
  23. Wray J, Radley-Smith R. Beyond the first year after pediatric heart or heart–lung transplantation: changes in cognitive function and behaviour. Pediatr Transplant. 2005;9(2):170–177
  24. Freier MC, Babikian T, Pivonka J, et al. A longitudinal perspective on neurodevelopmental outcome after infant cardiac transplantation. J Heart Lung Transplant. 2004;23(7):857–864
  25. Brosig C, Hintermeyer M, Zlotocha J, Behrens D, Mao J. An exploratory study of the cognitive, academic, and behavioral functioning of pediatric cardiothoracic transplant recipients. Prog Transplant. 2006;16(1):38–45
  26. Todaro JF, Fennell EB, Sears SF, Rodrigue JR, Roche AK. Review: cognitive and psychological outcomes in pediatric heart transplantation. J Pediatr Psychol. 2000;25(8):567–576
  27. Uzark KC, Sauer SN, Lawrence KS, Miller J, Addonizio L, Crowley DC. The psychosocial impact of pediatric heart transplantation. J Heart Lung Transplant. 1992;11(6):1160–1167
  28. Wray J, Radley-Smith R. Longitudinal assessment of psychological functioning in children after heart or heart–lung transplantation. J Heart Lung Transplant. 2006;25(3):345–352
  29. Mintzer LL, Stuber ML, Seacord D, Castaneda M, Mesrkhani V, Glover D. Traumatic stress symptoms in adolescent organ transplant recipients. Pediatrics. 2005;115(6):1640–1644
  30. Wray J, Radley-Smith R. Depression in pediatric patients before and 1 year after heart or heart–lung transplantation. J Heart Lung Transplant. 2004;23(9):1103–1110
  31. Rianthavorn P, Ettenger R, Malekzadeh M, Marik J, Struber M. Noncompliance with immunosuppressive medications in pediatric and adolescent patients receiving solid-organ transplants. Transplantation. 2004;15(5):778–782
  32. Sigfusson G, Fricker F, Bernstein D, et al. Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr. 1997;130(6):862–871
  33. Dew M, Roth L, Thompson M, Kormos R, Griffith B. Medical compliance and its predictors in the first year after heart transplantation. J Heart Lung Transplant. 1996;15(6):631–645
  34. Sredl D, Werner T, Springhart D, Watkins D, Shaner M, McBride G. An evidence-based pilot study exploring relationships between psychologic and physiologic factors in post-lung transplant adolescents with cystic fibrosis. J Pediatr Nurs. 2003;18(3):216–220
  35. Nevins TE. Non-compliance and its management in teenagers. Pediatr Transplant. 2002;6(6):475–479
  36. Shemesh E, Lurie S, Stuber M, et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics. 2000;105(2):E29
  37. Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics. 2004;113(4):825–832
  38. Beck D, Fennell R, Yost R, Robinson J, Geary D, Richards G. Evaluation of an educational program on compliance with medication regimens in pediatric patients with renal transplants. J Pediatr. 1980;96(6):1094–1097
  39. Shaw RJ, Palmer L, Blasey C, Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant. 2003;7(6):489–493
  40. Falkenstein K, Flynn L, Kirkpatrick B, Casa-Melley A, Dunn S. Non-compliance in children post-liver transplant. Who are the culprits?. Pediatr Transplant. 2004;8(3):233–236
  41. Ringewald J, Gidding S, Crawford S, Backer C, Mavroudis C, Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients. J Pediatr. 2001;139(1):75–80
  42. Meyers K, Thomson P, Weiland H. Noncompliance in children and adolescents after renal transplantation. Transplantation. 1996;62(2):186–189
  43. Meyers K, Weiland H, Thomson P. Paediatric renal transplantation non-compliance. Pediatr Nephrol. 1995;9(2):189–192
  44. Wolff G, Strecker K, Vester U, Latta K, Ehrich J. Non-compliance following renal transplantation in children and adolescents. Pediatr Nephrol. 1998;12(9):703–708
  45. Blowey D, Hebert D, Arbus G, Pool R, Korus M, Koren G. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol. 1997;11(5):547–551
  46. Watson AR. Non-compliance and transfer from pediatric to adult transplant unit. Pediatr Nephrol. 2000;14(6):469–472

PII: S1058-9813(07)00012-4

doi: 10.1016/j.ppedcard.2007.05.011

Progress in Pediatric Cardiology
Volume 23, Issue 1 , Pages 73-79 , September 2007

Article Tools

* Image Usage & Resolution